Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
R. Uraki, M. Kiso, K. Iwatsuki-Horimoto…·Y. Kawaoka
This study characterizes the in vitro and in vivo properties of the EG.5.1 SARS-CoV-2 variant, showing increased transmissibility and altered antigenicity compared to XBB.1.5.
R. Uraki, S. Iida, P. J. Halfmann…·Y. Kawaoka
This study evaluates the replicative ability and pathogenicity of SARS-CoV-2 BA.2.75 isolates in Syrian hamsters, finding higher lung replication and focal pneumonia compared to BA.2 and BA.5.
S. Murakami, T. Kitamura, H. Matsugo…·T. Horimoto
The paper isolates and characterizes SARS-CoV-2 clade sarbecoviruses from Japanese bats, showing host-specific replication and genetic variation in the S1 region.
M. Yamamoto, M. Kiso, Y. Sakai-Tagawa…·J.-i. Inoue
This study shows nafamostat inhibits SARS-CoV-2 infection in vitro by blocking TMPRSS2-mediated fusion, with potency exceeding its blood concentration, suggesting it as a potential COVID-19 treatment.